You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Drug Price Trends for HEMORRHOIDAL CREAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HEMORRHOIDAL CREAM

Average Pharmacy Cost for HEMORRHOIDAL CREAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HEMORRHOIDAL CREAM 70000-0425-01 0.07587 GM 2025-03-19
HEMORRHOIDAL CREAM 70000-0425-01 0.07529 GM 2025-02-19
HEMORRHOIDAL CREAM 70000-0425-01 0.07495 GM 2025-01-22
HEMORRHOIDAL CREAM 70000-0425-01 0.07667 GM 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for HEMORRHOIDAL CREAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
HEMORRHOIDAL CREAM United Drug Supply, Inc. 00113-0944-24 51GM 2.48 0.04863 GM 2023-12-01 - 2028-11-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Hemorrhoidal Cream Market Analysis and Price Projections

Market Overview

The market for hemorrhoidal treatments, including hemorrhoidal cream, is experiencing significant growth driven by several key factors. Here are some critical aspects to consider:

Growing Prevalence of Hemorrhoids

The increasing prevalence of hemorrhoids among the global population is a major driver of the market. Factors such as ageing, chronic constipation or diarrhea, obesity, and pregnancy contribute to the rising demand for efficient therapies[1][3][4].

Lifestyle Factors

Modern lifestyles, including prolonged sitting, poor dietary choices, and sedentary behaviors, are linked to the development of hemorrhoids. These lifestyle factors are common in many parts of the world, particularly in urban and industrialized regions, driving the demand for treatment options[1].

Improvements in Treatment Technologies

Advancements in medical treatments, such as minimally invasive surgical methods and innovative topical formulations, have made treatments less painful and more successful. These improvements are attracting more patients to seek medical attention, thereby expanding the market[1][3][4].

Better Healthcare Infrastructure

Enhancements in healthcare infrastructure and accessibility, especially in rising economies, make it easier for patients to seek treatment. This increased accessibility supports the market's expansion[1][3].

Growing Healthcare Spending

Increased spending on healthcare by both governments and private individuals makes treatments more accessible, contributing to the market's growth[1][3].

Public Health Campaigns and Education

Public health initiatives and educational campaigns about colorectal health raise awareness and encourage people to seek treatment, further supporting market growth[1][3].

Market Size and Forecast

  • The global hemorrhoids treatment market, which includes hemorrhoidal creams, is projected to grow significantly. For instance, the market size was valued at USD 3.5 billion in 2023 and is expected to reach USD 34.9 billion by 2030, growing at a CAGR of 24% during the forecast period 2024-2030[1].
  • Another projection indicates that the market will reach USD 2.45 billion by 2034, exhibiting a CAGR of 5.7% during 2024-2034[4].

Distribution Channels

The distribution of hemorrhoidal creams and other treatments occurs through various channels:

Hospital Pharmacies

Hospital pharmacies dominate the global revenue with a significant market share due to their collaboration with pharmaceutical companies and the presence of skilled healthcare professionals[3].

Retail Pharmacies

Retail pharmacies, including local drug stores and pharmacy chains, also play a crucial role in distributing hemorrhoidal creams and other treatments[1].

Online Pharmacies

Online pharmacies have gained traction due to their convenience, discounts, and other benefits, and are expected to have prominent growth during the forecast period[3].

Pricing and Affordability

The pricing of hemorrhoidal creams can vary based on the brand, quantity, and distribution channel.

  • For example, the cost for Hemorrhoidal Ointment 0.25% rectal ointment can range from $7.99 to $11.49 for a supply of 57 grams, depending on the pharmacy and availability[2].
  • Preparation H, a well-known brand, sold its hemorrhoidal cream/ointment/spray products at an average price of $9.46 in the United States in 2019[5].

Over-the-Counter (OTC) Products

OTC products, including hemorrhoidal creams, are gaining popularity due to their ease of access and convenience. These products, such as hydrocortisone creams and witch hazel pads, are preferred for their ability to reduce inflammation and alleviate discomfort without the need for a prescription[4].

Regional Market Analysis

North America

The United States has the largest patient pool for hemorrhoids and represents the biggest market for its treatment. This is attributed to the increasing prevalence, advancements in treatment options, and a shift towards patient-centered care[4].

Europe

The European region dominates the global hemorrhoid market due to the rising prevalence of hemorrhoids and the presence of advanced healthcare infrastructure with technological advancements in hemorrhoid treatment devices[3].

Asia Pacific

The growing healthcare expenditure in countries like Japan, China, and India is enhancing the expansion of the hemorrhoid treatment market in the Asia Pacific region. Increasing research activities to develop innovative and effective treatment procedures also support market growth in this region[3].

Key Players and Innovations

Companies like Citius Pharmaceuticals are advancing the development of innovative products. For example, CITI-002, an investigational drug by Citius Pharmaceuticals, is a novel topical formulation being studied for its potential to provide relief from hemorrhoid symptoms such as pain and inflammation[4].

Consumer Preferences and Empowerment

There is a significant shift towards patient empowerment and preventive health management. Consumers are turning to OTC remedies for managing hemorrhoid symptoms, reflecting a preference for accessible and self-care treatments[4].

Future Outlook

The future of the hemorrhoidal cream market looks promising due to the growing demand for efficient and accessible treatments. Here are some key points to consider:

  • Increased Awareness: As social stigma around hemorrhoids decreases and awareness about treatment options increases, more individuals are likely to seek medical attention.
  • Technological Advancements: Minimally invasive procedures and innovative topical formulations will continue to drive market growth.
  • Healthcare Infrastructure: Improvements in healthcare infrastructure, especially in rising economies, will make treatments more accessible.
  • Public Health Initiatives: Educational campaigns and public health initiatives will continue to raise awareness and encourage people to seek treatment.

Key Takeaways

  • The global hemorrhoids treatment market, including hemorrhoidal creams, is expected to grow significantly due to increasing prevalence, lifestyle factors, and advancements in treatment technologies.
  • The market is projected to reach USD 34.9 billion by 2030, with a CAGR of 24% during the forecast period.
  • OTC products and minimally invasive procedures are gaining traction due to their convenience and effectiveness.
  • Regional markets, particularly in North America and Europe, are driving the growth due to high prevalence and advanced healthcare infrastructure.
  • Innovations in treatment options and public health initiatives are expected to further support market expansion.

FAQs

What is the projected market size for the hemorrhoids treatment market by 2030?

The hemorrhoids treatment market is projected to reach USD 34.9 billion by 2030, growing at a CAGR of 24% during the forecast period 2024-2030[1].

What are the main factors driving the growth of the hemorrhoids treatment market?

The main factors include the growing prevalence of hemorrhoids, lifestyle factors, improvements in treatment technologies, better healthcare infrastructure, and increasing healthcare spending[1][3][4].

How do OTC products contribute to the hemorrhoids treatment market?

OTC products, such as hemorrhoidal creams and ointments, offer convenience and ease of access, enhancing the growth of the market. They are preferred for their ability to reduce inflammation and alleviate discomfort without the need for a prescription[4].

Which region dominates the global hemorrhoid market?

The European region currently dominates the global hemorrhoid market due to the rising prevalence of hemorrhoids and the presence of advanced healthcare infrastructure[3].

What role do public health campaigns play in the hemorrhoids treatment market?

Public health campaigns and educational initiatives raise awareness and encourage people to seek treatment, supporting market growth by motivating individuals to address their health issues proactively[1][3].

How are technological advancements impacting the hemorrhoids treatment market?

Technological advancements, such as minimally invasive procedures and innovative topical formulations, are making treatments less painful and more successful, driving market growth and attracting more patients to seek medical attention[1][3][4].

Sources

  1. Verified Market Research: Hemorrhoids Treatment Market Size, Share & Forecast.
  2. Drugs.com: Hemorrhoidal Ointment Prices, Coupons, Copay Cards & Patient Assistance.
  3. Market Data Forecast: Hemorrhoid Treatment Market Size, Share & Analysis, 2032.
  4. BioSpace: Hemorrhoids Market Estimated to Reach USD 2.45 Billion by 2034.
  5. Statista: Average price of the leading hemorrhoidal cream/ointment/spray brands in the United States in 2019.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.